IMVT icon

Immunovant

112 hedge funds and large institutions have $197M invested in Immunovant in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

14% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 44

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

39% less capital invested

Capital invested by funds: $322M → $197M (-$124M)

Holders
112
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.87M
Puts
$532K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$39.8M
2
$29.6M
3
$20.8M
4
$18.5M
5
$10.5M
6
$8.13M
7
$4.61M
8
$4.53M
9
$4.35M
10
$3.92M
11
$3.81M
12
$3.78M
13
$3.29M
14
$3.23M
15
$2.54M
16
$2.53M
17
$2.03M
18
$2.03M
19
$1.96M
20
$1.92M
21
$1.64M
22
$1.64M
23
$1.32M
24
$1.26M
25
$1.24M